Giving NOAC treatment at myocardial injury after non-cardiac surgery lowers major vascular complications - PACE-CME

Giving NOAC treatment at myocardial injury after noncardiac surgery lowers major vascular complications

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Edoxaban as alternative to warfarin after bioprosthetic valve surgery
Edoxaban as alternative to warfarin after bioprosthetic valve surgery
AHA 2024
Edoxaban as alternative to warfarin after bioprosthetic valve surgery
- Chisato Izumi, MD, PhD
Stopping aspirin after 1 month DAPT in ACS patients after stenting
Stopping aspirin after 1 month DAPT in ACS patients after stenting
ACC.24
Stopping aspirin after 1 month DAPT in ACS patients after stenting
- Gregg Stone, MD
Results with novel FXI inhibitor in AF set the stage for phase 3 trials
Results with novel FXI inhibitor in AF set the stage for phase 3 trials
AHA 2023
Results with novel FXI inhibitor in AF set the stage for phase 3 trials
- Christian Ruff, MD
International survey of secondary prevention of CHD
International survey of secondary prevention of CHD
ESC Congress 2023
International survey of secondary prevention of CHD
- John W. McEvoy, MD, PhD
- Joris Holtrop, MD